MGT Capital Investments Inc.  

(Public, NYSEMKT:MGT)   Watch this stock  
Find more results for MGT Gaming, Inc
+0.01 (0.35%)
After Hours: 2.86 -0.01 (-0.35%)
Jul 28, 7:59PM EDT  
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 2.87 - 2.98
52 week 0.15 - 5.58
Open 2.94
Vol / Avg. 0.00/6.81M
Mkt cap 70.02M
P/E     -
Div/yield     -
EPS -0.23
Shares 23.80M
Beta 1.99
Inst. own 12%
Aug 15, 2016
Q2 2016 MGT Capital Investments Inc Earnings Release (Estimated) Add to calendar
May 23, 2016
Q1 2016 MGT Capital Investments Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin - -3766.35%
Operating margin - -3071.15%
EBITD margin - -2385.58%
Return on average assets -95.37% -46.64%
Return on average equity -95.74% -48.03%
Employees 15 -
CDP Score - -


500 Mamaroneck Ave Ste 204
HARRISON, NY 10528-1600
United States - Map
+1-914-6307430 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


MGT Capital Investments, Inc. (MGT), through its subsidiaries, is engaged in the business of acquiring, developing and monetizing assets in the online and mobile gaming space, as well as the social casino industry. The Company operates through two segments: Gaming and Intellectual Property. MGT's gaming portfolio includes a social casino platform Slot Champ. It also includes minority stakes in the skill-based gaming platform MGT Play and fantasy sports operator DraftDay Gaming Group, Inc. (DDGG). The Company's subsidiaries include Medicsight, Inc. (Medicsight), MGT Sports, Inc. (MGT Sports), MGT Studios, Inc. (MGT Studios) and MGT Gaming, Inc. (MGT Gaming). Medicsight owns medical imaging software and has designed an automated carbon dioxide insufflation device on which the Company receives royalties from an international distributor. The software is designed to detect colorectal polyps during a virtual colonoscopy performed using computed tomography.

Officers and directors

Robert B. Ladd President, Interim Treasurer, Interim Chief Financial Officer, Director
Age: 57
Bio & Compensation  - Reuters
Roger Veras Vice Chairman of the Board
Bio & Compensation  - Reuters
Nolan K. Bushnell Independent Director
Age: 73
Bio & Compensation  - Reuters
H. Robert Holmes Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael Onghai Independent Director
Age: 45
Bio & Compensation  - Reuters